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IONTOPHORESIS OF LIDOCAINE FOR LOCAL ANESTHESIA 
Iontophoresis, also called "common ion transfer," 
utilizes direct current to induce the transfer of an ion 
across a body surface. The process was originally intro-
duced by Leduc"^  at the beginning of this century. Since 
that time there have been numerous reports of the iontophoresis 
2—6 
of medications for widely varying disorders. 
Iontophoresis of lidocaine with epinephrine induced 
excellent anesthesia of the tympanic membrane.^ ^ In 
dental work, iontophoresis of local anesthetic agents has 
been used for tooth extraction and treatment of infected 
tooth root canals. Gangarosa"^ reported minimal patient 
discomfort during tooth extraction using iontophoresis for 
deep surface anesthesia. He proposed that this procedure 
could eliminate a fear of hypodermic injections and therefore 
12 
promote a better patient-dentist relationship. Sisler also 
utilized iontophoresis for local anesthesia. He found anes-
thesia of the conjunctiva by this method very effective for 
surgery of the conjunctiva, subconjunctiva and superficial 
tarsus. 
This study was undertaken to compare the duration and 
depth of anesthesia produced by lidocaine and physiologic 
saline when administered by iontophoresis, subcutaneous infil-
tration and topical application. 
2 
Materials and Methods 
Subjects and Protocols. After receiving approval from the 
Review Committee for Research with Human Subjects at the 
University of Utah, the study was conducted in two phases. In 
Phase I, the duration of topical anesthesia achieved by using 
three administrative techniques with lidocaine and placebo 
was evaluated. In Phase II, the depth of anesthesia 
achieved following iontophoresis and subcutaneous infiltration 
of lidocaine was evaluated. The presence or absence of 
anesthesia was always determined by an evaluator not involved 
with the administration procedure. 
The research design of Phase I was a two factor 
randomized block design in which factor A (Method of 
Administration) consisted of three levels (iontophoresis, 
subcutaneous infiltration and swab) and factor B (Drug) con-
sisted of two levels (lidocaine and placebo). This design 
allowed for the determination of effects due to method of 
administration, drug and individual variation. Specific pairs 
of means were of special interest and compared by way of a_ 
priori planned comparisons. 
lidocaine, iontophoresis - lidocaine, infiltration 
lidocaine, iontophoresis - lidocaine, swab 
lidocaine, iontophoresis - placebo, iontophoresis 
Eligibility to enter the study was based on a normal 
physical examination, SGOT and alkaline phosphatase levels and 
a detailed medical and drug history. A history of allergic 
disease, abnormal laboratory values or allergic reaction to 
any drug disqualified a volunteer from participating in the 
study. Subjects unusually sensitive to sunlight were advised 
that they might experience a reaction similar to a mild sunburn. 
Twenty-nine healthy adult volunteers participated in the study. 
Twenty-seven completed Phase I. One subject withdrew due to 
side effects (hand muscle spasms) and another had difficulty 
evaluating the effects of the instrument used to elicit the 
pain stimuli. Twelve of these subjects participated in Phase II. 
The flexor surfaces of the subject's right and left 
forearms were used during the study. The surfaces were shaved, 
if necessary, and then given a surgical prep including a 
thorough defatting of the skin with acetone followed by 
cleaning with providone iodine surgical scrub. The soap 
residue was rinsed with sterile water and dried with a sterile 
towel. 
The assignment of the six method-drug sets (Table I) to 
the three sites on each forearm was randomized with constraint 
for each subject. Specifically, iontophoresis of lidocaine 
and placebo were not performed on the same forearm for any 
given subject. The procedure for the assignment of experimental 
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TABLE 1. The Six Method-Drug Sets 
Evaluated 
Set 1. iontophoresis - lidocaine 
Set 2. infiltration - lidocaine 
Set 3. swab - lidocaine 
Set 4. iontophoresis - placebo 
Set 5. infiltration - placebo 
Set 6. swab - placebo 
sets to the six sites was carried out as follows. Steps A 
through C occurred before the study began and were performed 
by persons other than the investigators or evaluator. 
A. Twenty-nine lists were prepared in which the method-drug 
Sets 1, 2, 3, 4, 5, and 6 were listed in random orders, 
with the constraint that either 1 or 4, but not both, 
would be one of the first three numbers. 
B. For each subject, each of the method-drug sets was 
assigned to a site. For example, if the random order 
list for the first subject was 3, 4, 6, 5, 2, and 1, 
then the lidocaine swab was applied to site 1, placebo 
iontophoresis to site 2, placebo swab to site 3, etc. 
C. Each of the method-drug sets was then coded so that the 
investigator would know only the site of administration. 
D. When the study began the investigator was given a packet 
of six sets for each subject with instructions for the 
site of administration of each set. This procedure 
resulted in a double-blind paradigm for the drug administered. 
Each subject was seated with elbows rested on a table 
and hands elevated. A blind-fold was used to cover the eyes. 
At no time during the study were the subjects allowed to see 
their arms. 
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Prior to the administration of the placebo and lidocaine, 
each subject was tested by a sterile 21g hypodermic needle 
being pressed at points along the flexor surface of the right 
and left forearms to ensure that the subject could feel and 
properly interpret the pain stimuli effected by the instrument. 
A sterile surgical marker was used to describe three circles, 
each 3 cm in diameter on each arm. These circles were used 
as guides for the administration of the drug or placebo. 
Drug Administration. The administration procedure in Phase I 
for each solution (drug or placebo) was as follows. 
Iontophoresis. An individual, throughly familiar with 
the concept of iontophoresis and the use of the electrodes and 
the iontophoretic device,'0 attached the positive electrode 
with the drug or placebo to the skin according to the random 
sequence described above. The negative electrode was attached 
to the extensor surface of the same forearm. Iontophoresis of 
c d 3 ml of placebo and 3 ml of 4% lidocaine was then carried out. 
The direct current was increased from 0 to 2 milliamperes (ma) 
slowly over the first minute, to A ma during the second 
minute and maintained at 4 ma for the remaining five minutes of 
iontophoresis. At the completion of iontophoresis, the current 
was slowly reduced to 0 ma before removal of the electrodes. 
Total duration of iontophoresis was seven minutes. During 
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this time, the subject was observed and questioned about any 
sensations and side effects e.g., tingling, warmth, burning 
similar to a mild sunburn. If any side effects were noted, 
iontophoresis was modified as necessary and the changes noted 
on the subject's data sheet. 
Subcutaneous infiltration. Using a 25g, 5/8 inch 
Q C 
needle, 1 ml of 27, lidocaine or placebo was administered 
subcutaneously at the center of the appropriate 3 cm circle 
by a registered nurse, three minutes after the start of 
iontophoresis. 
Topical administration. Four percent lidocaine^ or 
placebo0 was applied with a cotton swab by a registered 
nurse to the area within the appropriate 3 cm circle for 
30 seconds. This application was made six minutes after the 
start of iontophoresis. 
During administration of lidocaine, all subjects were 
observed for signs of hypersensitivity including pruritis, 
13 14 skin rash, tachycardia, and periorbital edema. Each 
subject was asked to report any of these findings to the 
Investigators if they should occur within 24 hours of admin-
istration. 
Administration site preparation for Phase II was the 
same as Phase I except that two additional circles were drawn 
8 
on the forearm to guide administration. Lidocaine was randomly 
administered to one arm by iontophoresis and to the other arm 
by infiltration. 
Evaluation. Following removal of the electrodes in Phase I, 
the subjects were evaluated for the presence of anesthesia. 
The evaluator applied the tip of a 21g hypodermic needle to 
each site of administration. Although the evaluator was 
unaware of which drug was administered to a site, in most cases 
iontophoresis produced mild erythema which made complete 
blinding impossible. Each site was evaluated at least every 
five minutes until at least five of the six sites were noted 
to lack anesthesia. Lack or loss of anesthesia was determined 
by the presence of "sharp" pain as described by the subject 
following application of the needle for two consecutive 
evaluations. Testing at that site was then discontinued. 
Duration of anesthesia was also evaluated as the change in 
concentration of lidocaine in the electrode blister following 
iontophoresis. 
To evalute the depth of anesthesia in Phase II, a 
000 silk suture^ was placed, full skin thickness incorporating 




Of the 27 subjects who completed Phase I, 17 (63 
percent) received lidocaine by iontophoresis according to the 
study protocol. Side effects during iontophoresis necessitated 
a voltage reduction in six subjects, shortened time of 
iontophoresis in three subjects, and reduced voltage and duration 
in one subject. Table 2 lists the duration of anesthesia 
achieved in each of the six method-drug sets. A correlated T 
test was the method of analysis for the three comparisons of 
interest. The mean duration of anesthesia produced by 
lidocaine iontophoresis was significantly shorter than with 
lidocaine infiltration (t0, = 4.48; p< .001). One subject 
L 0 
encountered a longer duration of anesthesia with lidocaine 
iontophoresis than with lidocaine infiltration. 
There was also a statistically significantly shorter 
duration of anesthesia produced by lidocaine iontophoresis 
than topical lidocaine application (^5 = 5.20; p<.001). 
Lidocaine iontophoresis produced significantly longer anesthesia 
than did placebo administered by any method (p<.001). 
Re-evaluation of the results using only those subjects 
able to complete the protocol as orginally described did not 
produce any change in the statistical significance of the 
differences between lidocaine iontophoresis and lidocaine 
infiltration . 
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Table 2. Results of six method-drug sets used to comparatively 
evaluate local anesthesia produced by lidocaine. 
Duration of Local Anesthesic 
Method-Drug Set Mean (min) Std Dev (min) Range (min) 
iontophoresis - lidocaine 14.5 9.5 1-39 + 
infiltration - lidocaine 22.2 7.3 2-39 + 
swab - lidocaine 2.1 6.5 0-25 
iontophoresis - placebo 0.8 1.7 0-7 
infiltration - placebo 1.9 3.1 0-14 
swab - placebo 1.7 5.7 0-27 
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An attempt was made to correlate the duration of 
anesthesia to the concentration of lidocaine in the electrode 
blister following iontophoresis. See Figure 1. The percentage 
of lidocaine remaining in the electrode blister at the end of ionto-
phoresis ranged from 78 to 95 percent, a significant correlation between 
this parameter and duration of anesthesia was not found (r = -.05). 
Twelve subjects participated in Phase II. The anes-
thetized area following lidocaine iontophoresis was readily 
recognized by the resulting erythema. Full thickness sutures 
were placed in each subject through the area anesthetized by 
iontophoresis and infiltration. A relative rating scale of 
sharp, dull or no pain was used by the subjects to describe the 
sensation experienced during suture placement. No subject 
reported a "sharp" pain. One subject reported a "dull" sensation 
during placement of the suture through the iontophoresed site. 
Side effects reported during the study included localized 
warmth, burning or cold by eight subjects. Six reports of 
stinging and one of dizziness were made. Two subjects reported 
hand spasm. In one, repositioning the electrode eliminated the 
hand spasm. The other subject withdrew from the study because 
of the discomfort from the iontophoretic device. 
Discussion 
Direct current passes through electrolyte solutions 
by virtue of the migration of ions. Under the influence of the 
12 
Figure 1. Plot of the percentage of lidocaine remaining in the 
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current, ions travel toward the oppositely charged pole. This 
movement of ions under electrical influence is called ion 
transfer. Iontophoresis is the term used to describe this 
phenomenon when used for medical purposes. 
Lidocaine has a pK^ of 7.9 and is therefore 95 percent 
ionized at a pH of approximately six. Since the ion carries a 
positive charge, the solution is placed under the positive 
electrode. With the application of direct current, the drug 
ions travel into the epidermis, and exert pharmacological 
action. ^  Gangarosa et al^ studied the conductivity of drugs 
used for iontophoresis. Lidocaine and other local anesthetics 
were found to conduct best at a pH of approximately five. 
Increasing the pH decreases the number of ionized molecules, 
and may decrease the conductivity of lidocaine. However, 
successful local anesthesia may be attained even if the pH ap-
proaches the pK&. 
Studies with drugs such as methacholine have demonstrated 
that physiologic effects are produced. It is iontophoresis 
of the drug, not simply the passage of current through saline, 
that is responsible for the effects observed.^ This study 
confirms these findings with the anesthetic lidocaine. The data 
in Table 2 indicate that the iontophoresis of lidocaine 
produces a significantly longer duration of anesthesia than 
14 
the administration of physiologic saline by any method. Of 
the 27 subjects, 20 noted no anesthesia and only one subject 
reported anesthesia of longer than five minutes with 
placebo iontophoresis. 
The iontophoresis procedure recommended by the 
manufacturer of the iontophoretic device was followed in this 
18 
study. Our findings indicate that local anesthesia with 
lidocaine iontophoresis can be accomplished by this procedure. 
The depth of anesthesia achieved was the same as that achieved 
using lidocaine infiltration. The average duration of 
anesthesia was sufficient to allow completion of brief 
(5 minutes) procedures requiring local anesthesia for 23 
(85 percent) of our subjects. 
The anesthesia produced by lidocaine iontophoresis 
was of shorter duration than that achieved by lidocaine 
infiltration. The mean + SD duration of anesthesia with 
lidocaine infiltration was 22.2 +7.3 minutes. The mean + 
SD duration of anesthesia produced by lidocaine iontophoresis 
was 14.5 + 9.5 minutes. The difference in mean duration of 
anesthesia would have been greater had the study been con-
tinued until all subjects noted the loss of anesthesia from 
all sites. The shorter duration of anesthesia with iontophoresis 
may be explained by partial loss of the lidocaine during the 
iontophoretic period before the evaluation procedure was 
15 
initiated. Iontophoresis will cause localized capillary 
dilatation resulting in increased regional blood flow which 
19 
may hasten the elimination of lidocaine from the site. 
Other variables can also influence the iontophoresis 
of a drug.^ The strength of the current (4 ma), solution 
concentration (4 percent), pH (6), duration of iontophoresis 
(7 minutes) and presence of competitive anions in the solution 
were constant in this study. Differences between subjects in 
regional blood flow, skin thickness, quantity of hair follicles 
and sweat glands per unit surface area, thoroughness of 
cleansing of the skin prior to iontophoresis and the method of 
attachment of the electrodes may also contribute to a variable 
duration of anesthesia. The effect of the last two factors 
were constant in this study. No attempt was made to evaluate 
skin thickness, regional blood flow or quantity of hdir fol-
licles and sweat glands per unit surface area, although the 
flexor surface of each forearm was a consistent administration 
site for each subject, and subjects served as their own 
controls. 
The standard deviation was large for both lidocaine 
iontophoresis and the more commonly used infiltration technique. 
Table 3 shows the range of duration of anesthesia. The wide 
range of duration may have been due to the subjective method of 
evaluation (subject self-report). No accurate noninvasive method 
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Table 3. Distribution of the duration of anesthesia achieved 
using iontophoresis and infiltration of lidocaine. 
lidocaine-iontophoresis lidocaine-infiltration 
Cumulative Cumulative 
Duration Absolute Adjusted Absolute Adjusted 
(min) Frequency Frequency (%) Frequency Frequency (%) 
0-5 4 14.8 1 3.7 
6-10 9 48.1 1 7.4 
11-15 2 55.9 1 11.1 
16-20 5 74.1 6 33.3 
21-25 4 88.9 10 70.4 
26-30 1 92.6 6 92.6 
31-40 2 100.0 2 100.0 
17 
determining the return of nerve function following local 
anesthesia has been reported. Recovery from blockade is 
an exponential process, rapid at first and then slowing grad-
ually as normal function returns. The moment of complete 
return to normal nerve function is difficult to determine 
20 
precisely. The drug and the method of evaluation were common 
to both drug-method sets. The method of administration was not. 
Prolongation of anesthesia achieved with iontophoresis 
can be accomplished by adding epinephrine to the electrode. 
The localized vasoconstriction caused by epinephrine decreases 
regional blood flow and diffusion of lidocaine from the site of 
9 
action. Comeau and Brummett reported the duration of anesthesia 
of the tympanic membrane to be approximately 20 minutes with a 
solution of 2 percent lidocaine and 1:100,000 epinephrine. The 
duration increased to approximately 100 minutes with a-change in 
the epinephrine concentration to 1:2,000 while all other variables 
were held constant. Gangarosa et al^ reported optimal vaso-
constriction and deep topical anesthesia of the oral mucosa, ear 
canal and skin using 2 percent lidocaine with 1:12,500 - 1:50,000 
epinephrine. If epinephrine had been added to lidocaine in our 
study, the duration of anesthesia induced by iontophoresis may have 
been increased. 
Side effects during this study included localized warmth, 
burning, cold and stinging, and were attributed to the iontophoresis 
18 
by the subjects. All reactions subsided rapidly after modification 
19 
or discontinuance of the procedure. Griffith and Karselis suggest 
2 
a maximal current rate of 1 ma/cm to prevent burns to the skin. 
2 
This study employed a rate of 0.65 ma/cm . The iontophoresis 
of a local anesthetic has the potential hazard that the anesthetic 
may prevent a patient from being aware of a burn. 
The results of this study demonstrate that lidocaine 
iontophoresis is an effective means of achieving local anesthesia 
for approximately five minutes without requiring the use of a 
hypodermic needle and syringe. This technique may be useful 
when local anesthesia must be achieved in patients with an aversion 
to the use of hypodermic needles. Induction of anesthesia by ion-
tophoresis may also be used to avoid further trauma to tissues 
surrounding an abscess prior to its incision and drainage or prior 
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DURATION OF ANESTHESIA (MINUTES) 
Lidocaine Lidocaine Lidocaine 
Subject Iontophoresis Infiltration Topical 
1 13 2 0 
2 7 28 0 
3 32 32 0 
4 7 23 0 
5 11 20 0 
6 10 22 0 
7 5 25 0 
8 6 6 0 
9 8 16 0 
10 21 21 1 
11 10 27 0 
12 39 39 0 
13 24 24 3 
14 1 21 0 
15 28 28 0 
16 10 14 0 
17 16 26 0 
18 19 19 0 
19 18 21 4 
20 2 19 0 
21 9 28 24 
22 25 29 0 
23 19 19 0 
24 20 20 0 
25 5 22 0 
26 7 25 25 
27 21 23 0 
Mean 14.5 22.2 2.1 
Std. Dev. 9.5 7.3 6.5 
Range 1-39 2-39 0-25 
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PLACEBO 
DURATION OF ANESTHESIA (MINUTES) 
Placebo Placebo Placebo 























































Mean 0.8 1.9 1.7 
Std. Dev. 1.7 3.1 5.7 
Range 0-7 0-14 0-27 
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PERCENTAGE OF LIDOCAINE REMAINING IN THE ELECTRODE AND THE 






















































































* not determined 
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